Merck & Co., Inc.
MRK
Revenue
16.11B
▲337.00M▲2.14%
3 Months ChangeAssets
112.63B
▲6.78B▲6.41%
3 Months ChangeLiabilities
69.05B
▲3.56B▲5.44%
3 Months ChangeFree Cash Flow
2.23B
▲1.90B▲571.39%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001104659-24-112841
2024-08-05
Form 10-Q
ID: 0001628280-24-034715
2024-07-30
Form 8-K
ID: 0001104659-24-083722
2024-05-30
Form 8-K
ID: 0001628280-24-025800
2024-05-03
Form 10-Q
ID: 0001628280-24-020283
2024-04-25
Form 8-K
ID: 0001104659-24-051517
2024-02-20
Form 8-K
ID: 0001104659-24-025524
2024-02-01
Form 8-K
ID: 0001104659-24-009109
2023-11-28
Form 8-K
ID: 0001104659-23-121671
2023-11-03
Form 10-Q
ID: 0001628280-23-036717